Compass Therapeutics, Inc. · NASDAQ:CMPX

Lerner Neil bought 10,000 Compass Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 18, 2026

On Nov 17, 2026, Lerner Neil (Chief Accounting Officer) bought 10,000 Compass Therapeutics, Inc. shares at US$0.59 for US$5,900, leaving 430,000 shares. Filed Nov 18, 2026 (Form 4).

Bought
10,000 shares
Price
US$0.59
Value
US$5,900
Holding after
430,000 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockBuy10,000US$0.59430,000Direct

Source

Download original · View original at SEC

Related